Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GGHCX vs. RYHIX: which is better?

Bottom line

GGHCX vs RYHIX: the short answer

GGHCX (INVESCO Health Care Fund) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 52% by weight.

GGHCX is cheaper at 1.07% vs 1.38% — a difference of $31 a year per $10,000 invested.

Over five years, RYHIX returned +5.1% a year vs +2.6% for GGHCX.

GGHCX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

GGHCX vs RYHIX side by side

GGHCXRYHIX
TypeMutual fundMutual fund
Fund familyInvescoGuggenheim
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.07%1.38%
Annual cost per $10k$107$138
10-yr cost on $10k (prospectus)$1,784$1,709
Max front load5.5%—
12b-1 fee0.25%0%
1-yr return+9.2%+14.4%
5-yr return (annualized)+2.6%+5.1%
10-yr return (annualized)+5.8%+7.9%
Best quarter+19.6%+18.7%
Worst quarter−16.5%−14.4%
Net assets (fund)$1.2B$19.4M
Number of holdings82135
Portfolio turnover59%244%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearGGHCXRYHIXDifference
2025+15.5%+14.4%+1.1%
2024+4.0%+0.6%+3.4%
2023+3.1%+5.8%−2.8%
2022−13.5%−11.6%−1.9%
2021+12.2%+19.2%−7.0%
2020+14.5%+18.9%−4.5%
2019+32.0%+22.8%+9.2%
2018+0.5%+1.6%−1.1%
2017+15.5%+23.5%−8.0%
2016−11.7%−9.4%−2.3%

Source: Fund prospectus bar charts

Holdings overlap

11 of GGHCX's top 25 holdings also appear in RYHIX's top 25.

Shared top holdings
HoldingGGHCXRYHIX
Eli Lilly and Co.10.59%3.63%
Johnson & Johnson6.76%2.88%
UnitedHealth Group Inc.6.17%2.22%
Merck & Co., Inc.4.59%2.04%
AbbVie Inc.4.03%2.52%
Gilead Sciences, Inc.3.63%1.39%
CVS Health Corp.2.52%1.31%
Cardinal Health, Inc.2.10%0.86%
Vertex Pharmaceuticals Inc.2.01%1.34%
Edwards Lifesciences Corp.1.56%0.84%
Thermo Fisher Scientific Inc.1.55%1.61%

Source: SEC Form N-PORT

GGHCX top 10

  1. Eli Lilly and Co. — 10.59%
  2. Johnson & Johnson — 6.76%
  3. UnitedHealth Group Inc. — 6.17%
  4. Invesco Private Prime Fund — 4.67%
  5. Merck & Co., Inc. — 4.59%
  6. AbbVie Inc. — 4.03%
  7. Gilead Sciences, Inc. — 3.63%
  8. argenx SE — 3.24%
  9. CVS Health Corp. — 2.52%
  10. Welltower Inc. — 2.34%

RYHIX top 10

  1. Eli Lilly & Company — 3.63%
  2. Johnson & Johnson — 2.88%
  3. Abbvie Inc — 2.52%
  4. Unitedhealth Group Inc — 2.22%
  5. Merck & Company Inc — 2.04%
  6. Thermo Fisher Scientific Inc — 1.61%
  7. Amgen Inc — 1.56%
  8. Abbott Laboratories — 1.42%
  9. Gilead Sciences Inc — 1.39%
  10. Vertex Pharmaceuticals Inc — 1.34%

FAQ

What is the difference between GGHCX and RYHIX?
GGHCX (INVESCO Health Care Fund) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 52% by weight. GGHCX is cheaper at 1.07% vs 1.38% — a difference of $31 a year per $10,000 invested.
Which is cheaper, GGHCX or RYHIX?
GGHCX has the lower expense ratio (1.07%).
Should I own both GGHCX and RYHIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.